TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (TFFP) Q3 2020 Earnings Conference Call November 5, 2020 16:30 ET Company Participants Paul Sagan - Investor Relations Glenn Mattes - President and Chief Executive Officer Kirk Coleman - Chief Financial Officer Dale Christensen - Director, Clinical Development Chris Cano - Chief Operating Officer Bill Williams - Professor, University of Texas, Austin Conference Call Participants Jonathan Aschoff - ROTH Daniel Carlson - Tailwinds Research William Morrison - National Securities Doug Russell - Brown Harris Stevens Presentation Operator Good afternoon, ladies and gentlemen and welcome to the TFF Pharmaceuticals’ Third Quarter 2020 Financial Results. I would now like to turn the call over to your host, Mr. Paul Sagan of TFF Pharmaceuticals, Investor Relations. You may begin your conference. Paul Sagan Thank you very much, operator. Hello, everyone and welcome to TFF Pharmaceuticals third quarter 2020 financial and business results conference call. With me on the line today
For further details see:
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call Transcript